Current investments - CSAM
CSAM is the leading provider of niche eHealth solutions in the Nordics. The company’s software solutions enable healthcare providers to access relevant clinical information at the point of care. CSAM’s portfolio of products includes the leading maternity software, blood management software, medical imaging software (non-radiology), oncology medication software, connected healthcare software and emergency and acute software in the Nordics. Headquartered in Oslo, Norway, CSAM has 140 employees and nine offices operating in five countries, including a fully-owned software engineering subsidiary in the Philippines.
CSAM Health acquires Paratus Emergency Response Business from Saab and the acquisition will strengthen CSAM’s position in the emergency and …
For further information, please contact
Louise Nilsson is Partner and CEO. In addition to leading and developing Priveq, she is responsible for sourcing new investment opportunities, in which Priveq will contribute with growth and value creation as well as implement growth strategies in cooperation with other owners, the board and management.
Since Louise joined Priveq in 1998, she has, among others, been responsible for the ownership in Carmel Pharma, Hemtex, Swedish Orphan International and Vårdapoteket. She is currently a Director of the Boards in 21 Grams, CSAM Health, Metenova, Plint and Ports Group.
Prior to Priveq, Louise worked as chartered accountant for ÖhrlingsCoopers & Lybrand (current PwC) for nine years, with responsibility for small and medium-sized owner-led companies.
Louise holds a B.Sc. in Business Administration from Luleå University.